College of Human and Health Sciences, Swansea University, Swansea, Wales, United Kingdom.
Cardiff and Vale University Health Board, Wales, United Kingdom.
PLoS One. 2019 Sep 11;14(9):e0220885. doi: 10.1371/journal.pone.0220885. eCollection 2019.
Preventable adverse effects of medicines often pass unnoticed, but lead to real harm.
Nurse-led monitoring using the structured Adverse Drug Reaction (ADRe) Profile identifies and addresses adverse effects of mental health medicines.
This study investigated the implementation and clinical impact of ADRe, and barriers to and facilitators of sustained utilisation in routine practice.
Administration of ADRe was observed for 30 residents prescribed mental health medicines in ten care homes. The study pharmacist reviewed completed ADRes against medication records. Policy context was explored in 30 interviews with service users, nurse managers and strategic leads in Wales.
Residents were aged 60-95, and prescribed 1-17 (median 9 [interquartile range (IQR) 7-13]) medicines. ADRe identified a median of 18 [IQR 11.5-23] problems per resident and nurses made 2 [1-2] changes to care per resident. For example: falls were reported for 9 residents, and care was modified for 5; pain was identified in 8 residents, and alleviated for 7; all 6 residents recognised as dyspnoeic were referred to prescribers. Nurses referred 17 of 30 residents to prescribers. Pharmacists recommended review for all 30. Doubts about administering ADRe, sometimes expressed by people who had not yet used it, diminished as it became familiar. ADRe was needed to bridge communication between resident, nurses and prescribers. When barriers of time, complacency, and doctors' non-availability were overcome, reporting with ADRe made prescribers more likely to heed nurses' concerns regarding residents' welfare. Clinical gains were facilitated by one-to-one time, staff-resident relationships, and unification of documentation.
To our knowledge, ADRe is the only instrument that brings a full account of patients' problems to medication reviews. This juxtaposition of signs and symptoms against prescriptions facilitates dose adjustments and de-prescribing and leads to: reduced pain and sedation; early identification of problems linked to ADRs, such as falls; and timely medication reviews e.g. for dyspnoea.
药物的可预防不良反应常常被忽视,但却会造成实际危害。
护士主导的药物不良反应(ADR)监测使用结构化的 ADR 简介表来识别和处理精神健康药物的不良反应。
本研究调查了 ADR 的实施情况和临床影响,以及在常规实践中持续使用的障碍和促进因素。
在威尔士的 10 家养老院中,观察了 30 名服用精神健康药物的居民的 ADR 简介表的使用情况。研究药剂师对照药物记录对完成的 ADR 简介表进行了审查。对 30 名服务使用者、护士经理和战略领导进行了 30 次访谈,以探讨政策背景。
居民年龄为 60-95 岁,服用 1-17 种(中位数 9 [四分位距 7-13])药物。ADR 简介表每居民识别出 18 [11.5-23]个问题,护士每居民做出 2 [1-2]项护理变更。例如:9 名居民报告有跌倒,对 5 名居民进行了护理修改;8 名居民有疼痛,对 7 名居民进行了缓解;6 名呼吸困难的居民都被转介给了处方医生。护士将 17 名居民转介给了处方医生。药剂师建议对所有 30 名居民进行审查。那些尚未使用 ADR 简介表的人,有时会对其产生怀疑,但随着熟悉程度的提高,这种怀疑逐渐减少。ADR 简介表需要在居民、护士和处方医生之间进行沟通。当克服了时间、自满和医生无法获得的障碍时,通过 ADR 进行报告使处方医生更有可能关注护士对居民福利的担忧。通过一对一的时间、员工与居民的关系以及文档的统一,促进了临床获益。
据我们所知,ADR 是唯一能将患者问题的完整情况呈现给药物审查的工具。这种将症状与处方并列的方法促进了剂量调整和减药,并导致:疼痛和镇静减轻;早期识别与 ADR 相关的问题,如跌倒;及时进行药物审查,例如呼吸困难。